Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

Immunosuppressive treatment with everolimus in patients after orthotopic liver transplantation: 4 years of experience.

Wasilewicz MP, Moczydłowska D, Janik M, Grąt M, Zieniewicz K, Raszeja-Wyszomirska J.

Pol Arch Intern Med. 2019 Sep 10. doi: 10.20452/pamw.14968. [Epub ahead of print]

2.

Fulminant liver failure following a marathon: Five case reports and review of literature.

Figiel W, Morawski M, Grąt M, Kornasiewicz O, Niewiński G, Raszeja-Wyszomirska J, Krasnodębski M, Kowalczyk A, Hołówko W, Patkowski W, Zieniewicz K.

World J Clin Cases. 2019 Jun 26;7(12):1467-1474. doi: 10.12998/wjcc.v7.i12.1467.

3.

Depression in patients with autoimmune hepatitis: the need for detailed psychiatric assessment.

Janik MK, Wunsch E, Moskwa M, Raszeja-Wyszomirska J, Krawczyk M, Milkiewicz P.

Pol Arch Intern Med. 2019 Sep 30;129(9):645-647. doi: 10.20452/pamw.14898. Epub 2019 Jul 12. No abstract available.

4.

Intermittent high-flux albumin dialysis with continuous venovenous hemodialysis for acute-on-chronic liver failure and acute kidney injury.

Niewinski G, Raszeja-Wyszomirska J, Hrenczuk M, Rozga A, Malkowski P, Rozga J.

Artif Organs. 2019 Jul 2. doi: 10.1111/aor.13532. [Epub ahead of print]

PMID:
31267563
5.

Renaissance of Modified Charlson Comorbidity Index in Prediction of Short- and Long-Term Survival After Liver Transplantation?

Niewiński G, Graczyńska A, Morawiec S, Raszeja-Wyszomirska J, Wójcicki M, Zieniewicz K, Główczyńska R, Grąt M.

Med Sci Monit. 2019 Jun 18;25:4521-4526. doi: 10.12659/MSM.914669.

6.

Acute liver injury, acute liver failure and acute on chronic liver failure: A clinical spectrum of poisoning due to Gyromitra esculenta.

Arłukowicz-Grabowska M, Wójcicki M, Raszeja-Wyszomirska J, Szydłowska-Jakimiuk M, Piotuch B, Milkiewicz P.

Ann Hepatol. 2019 May - Jun;18(3):514-516. doi: 10.1016/j.aohep.2018.11.009. Epub 2019 Apr 15.

7.

Etiology of Liver Disease and Cardiovascular Abnormalities in Patients on a Liver Transplantation Waiting List.

Galas M, Glówczyńska R, Lewandowski Z, Cacko A, Raszeja-Wyszomirska J, Milkiewicz P, Krawczyk M, Zieniewicz K, Opolski G.

Ann Transplant. 2019 Mar 22;24:162-167. doi: 10.12659/AOT.913061.

8.

Depression: An Overlooked Villain in Autoimmune Hepatitis?

Janik MK, Wunsch E, Raszeja-Wyszomirska J, Krawczyk M, Milkiewicz P.

Hepatology. 2019 Feb 17. doi: 10.1002/hep.30568. [Epub ahead of print]

PMID:
30773711
9.

Long-Term Health-Related Quality of Life in Living Liver Donors.

Janik MK, Księżopolska A, Kostrzewa K, Kobryń K, Moskwa M, Raszeja-Wyszomirska J, Kornasiewicz O, Patkowski W, Milkiewicz P, Krawczyk M, Zieniewicz K.

Ann Transplant. 2019 Jan 22;24:45-51. doi: 10.12659/AOT.911109.

10.

Gut Permeability Might be Improved by Dietary Fiber in Individuals with Nonalcoholic Fatty Liver Disease (NAFLD) Undergoing Weight Reduction.

Krawczyk M, Maciejewska D, Ryterska K, Czerwińka-Rogowska M, Jamioł-Milc D, Skonieczna-Żydecka K, Milkiewicz P, Raszeja-Wyszomirska J, Stachowska E.

Nutrients. 2018 Nov 18;10(11). pii: E1793. doi: 10.3390/nu10111793.

11.

Effects of liver transplantation on health-related quality of life in patients with primary biliary cholangitis.

Krawczyk M, Koźma M, Szymańska A, Leszko K, Przedniczek M, Mucha K, Foroncewicz B, Pączek L, Moszczuk B, Milkiewicz P, Raszeja-Wyszomirska J.

Clin Transplant. 2018 Dec;32(12):e13434. doi: 10.1111/ctr.13434. Epub 2018 Dec 6.

PMID:
30362634
12.

Effect of S-adenosyl-L-methionine on liver biochemistry and quality of life in patients with primary biliary cholangitis treated with ursodeoxycholic acid. A prospective, open label pilot study.

Wunsch E, Raszeja-Wyszomirska J, Barbier O, Milkiewicz M, Krawczyk M, Milkiewicz P.

J Gastrointestin Liver Dis. 2018 Sep;27(3):273-279. doi: 10.15403/jgld.2014.1121.273.icz.

13.

Autoimmune hepatitis exerts a profound, negative effect on health-related quality of life: A prospective, single-centre study.

Janik MK, Wunsch E, Raszeja-Wyszomirska J, Moskwa M, Kruk B, Krawczyk M, Milkiewicz P.

Liver Int. 2019 Jan;39(1):215-221. doi: 10.1111/liv.13960. Epub 2018 Sep 29.

PMID:
30204306
14.

Pretransplant QT Interval: The Relationship with Severity and Etiology of Liver Disease and Prognostic Value After Liver Transplantation.

Główczyńska R, Galas M, Ołdakowska-Jedynak U, Peller M, Tomaniak M, Raszeja-Wyszomirska J, Milkiewicz P, Krawczyk M, Zieniewicz K, Opolski G.

Ann Transplant. 2018 Sep 4;23:622-630. doi: 10.12659/AOT.908769.

15.

PNPLA3 p.I148M and TM6SF2 p.E167K variants do not predispose to liver injury in cholestatic liver diseases: A prospective analysis of 178 patients with PSC.

Kruk B, Liebe R, Milkiewicz M, Wunsch E, Raszeja-Wyszomirska J, Lammert F, Milkiewicz P, Krawczyk M.

PLoS One. 2018 Aug 30;13(8):e0202942. doi: 10.1371/journal.pone.0202942. eCollection 2018.

16.

The Pre-Transplant Profile of Cardiovascular Risk Factors and Its Impact on Long-Term Mortality After Liver Transplantation.

Główczyńska R, Galas M, Witkowska A, Ołdakowska-Jedynak U, Raszeja-Wyszomirska J, Krasuski K, Milkiewicz P, Krawczyk M, Zieniewicz K, Opolski G.

Ann Transplant. 2018 Aug 21;23:591-597. doi: 10.12659/AOT.908771.

17.

Are the proprotein convertase subtilisin/kexin type 9 inhibitors new therapeutic chance for patients with familial hypercholesterolaemia and liver failure?

Glowczynska R, Hus A, Raszeja-Wyszomirska J, Opolski G.

Eur Heart J. 2018 Jul 14;39(27):2602. doi: 10.1093/eurheartj/ehy361. No abstract available.

PMID:
29945181
18.

Successful DAA-Based Treatment of Hcv-Related Fibrosing Cholestatic Hepatitis After Liver Transplantation Due to a Fulminant Liver Failure.

Krawczyk M, Gawęda B, Kośnik A, Rejowski S, Remiszewski P, Krawczyk M, Milkiewicz P, Raszeja-Wyszomirska J.

Am J Gastroenterol. 2018 Jul;113(7):1062-1063. doi: 10.1038/s41395-018-0078-8. Epub 2018 Jun 21. No abstract available.

PMID:
29925910
19.

Does transient elastography correlate with liver fibrosis in patients with PSC? Laennec score-based analysis of explanted livers.

Krawczyk M, Ligocka J, Ligocki M, Raszeja-Wyszomirska J, Milkiewicz M, Szparecki G, Ilczuk T, Górnicka B, Zieniewicz K, Krawczyk M, Lammert F, Milkiewicz P.

Scand J Gastroenterol. 2017 Dec;52(12):1407-1412. doi: 10.1080/00365521.2017.1370009. Epub 2017 Aug 29.

PMID:
28851259
20.

Effects of continuous use of probiotics before liver transplantation: A randomized, double-blind, placebo-controlled trial.

Grąt M, Wronka KM, Lewandowski Z, Grąt K, Krasnodębski M, Stypułkowski J, Hołówko W, Masior Ł, Kosińska I, Wasilewicz M, Raszeja-Wyszomirska J, Rejowski S, Bik E, Patkowski W, Krawczyk M.

Clin Nutr. 2017 Dec;36(6):1530-1539. doi: 10.1016/j.clnu.2017.04.021. Epub 2017 May 4.

PMID:
28506447
21.

Good outcome following liver transplantation using pericardial-peritoneum window for hepato-atrial anastomosis to overcome advanced hepatic alveolar echinococcosis and secondary Budd-Chiari Syndrome - a case report.

Kobryń K, Paluszkiewicz R, Dudek K, Ołdakowska-Jedynak U, Korba M, Raszeja-Wyszomirska J, Remiszewski P, Grąt M, Milkiewicz P, Patkowski W, Krawczyk M.

BMC Surg. 2017 Jan 13;17(1):5. doi: 10.1186/s12893-017-0205-2.

22.

A novel approach to genome-wide association analysis identifies genetic associations with primary biliary cholangitis and primary sclerosing cholangitis in Polish patients.

Paziewska A, Habior A, Rogowska A, Zych W, Goryca K, Karczmarski J, Dabrowska M, Ambrozkiewicz F, Walewska-Zielecka B, Krawczyk M, Cichoz-Lach H, Milkiewicz P, Kowalik A, Mucha K, Raczynska J, Musialik J, Boryczka G, Wasilewicz M, Ciecko-Michalska I, Ferenc M, Janiak M, Kanikowska A, Stankiewicz R, Hartleb M, Mach T, Grzymislawski M, Raszeja-Wyszomirska J, Wunsch E, Bobinski T, Mikula M, Ostrowski J.

BMC Med Genomics. 2017 Jan 6;10(1):2. doi: 10.1186/s12920-016-0239-9.

23.

Heterozygous Inactivation of the Nuclear Receptor PXR/NR1I2 in a Patient With Anabolic Steroid-Induced Intrahepatic Cholestasis.

Liebe R, Krawczyk M, Raszeja-Wyszomirska J, Kruk B, Preis R, Trottier J, Barbier O, Milkiewicz P, Lammert F.

Hepat Mon. 2016 Jul 23;16(8):e35953. eCollection 2016 Aug.

24.

Plasmapheresis exerts a long-lasting antipruritic effect in severe cholestatic itch.

Krawczyk M, Liebe R, Wasilewicz M, Wunsch E, Raszeja-Wyszomirska J, Milkiewicz P.

Liver Int. 2017 May;37(5):743-747. doi: 10.1111/liv.13281. Epub 2016 Nov 17.

PMID:
27778443
25.

Nutritional Strategies for the Individualized Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD) Based on the Nutrient-Induced Insulin Output Ratio (NIOR).

Stachowska E, Ryterska K, Maciejewska D, Banaszczak M, Milkiewicz P, Milkiewicz M, Gutowska I, Ossowski P, Kaczorowska M, Jamioł-Milc D, Sabinicz A, Napierała M, Wądołowska L, Raszeja-Wyszomirska J.

Int J Mol Sci. 2016 Jul 22;17(7). pii: E1192. doi: 10.3390/ijms17071192.

26.

Hepatic abscess: a rare complication after liver transplant.

Kornasiewicz O, Hołówko W, Grąt M, Gorski Z, Dudek K, Raszeja-Wyszomirska J, Krawczyk M.

Clin Transplant. 2016 Oct;30(10):1230-1235. doi: 10.1111/ctr.12807. Epub 2016 Sep 5.

PMID:
27409774
27.

Factors Affecting Exercise Test Performance in Patients After Liver Transplantation.

Kotarska K, Wunsch E, Jodko L, Raszeja-Wyszomirska J, Bania I, Lawniczak M, Bogdanos D, Kornacewicz-Jach Z, Milkiewicz P.

Hepat Mon. 2016 Mar 21;16(3):e34356. doi: 10.5812/hepatmon.34356. eCollection 2016 Mar.

28.

A rare but life-threatening complication in liver transplant recipients.

Raszeja-Wyszomirska J, Wasilewicz MP, Szydłowska-Jakimiuk M, Grzelak I, Figiel W, Sachs W, Niewiński G, Gierej B, Ziarkiewicz-Wróblewska B, Krawczyk M.

Prz Gastroenterol. 2016;11(1):62-4. doi: 10.5114/pg.2015.52562. Epub 2015 Jun 26. No abstract available.

29.

Orthotopic liver transplantation (OLTx) in non-cirrhotic portal hypertension secondary to ADAMTS13 deficiency.

Raszeja-Wyszomirska J, Wasilewicz M, Andrzejewska A, Dudek K, Figiel W, Urasińska E, Ziarkiewicz-Wróblewska B, Milkiewicz P, Krawczyk M.

Prz Gastroenterol. 2016;11(1):56-8. doi: 10.5114/pg.2015.52468. Epub 2015 Jun 22. No abstract available.

30.

The impact of osteoporosis on health-related quality of life in patients after liver transplantation - a pilot study.

Raszeja-Wyszomirska J, Kucharski R, Kotarska K, Zalewska M, Miazgowski T.

Prz Gastroenterol. 2015;10(4):215-21. doi: 10.5114/pg.2015.52343. Epub 2015 Jun 19.

31.

Metabolic risk factors of coronary heart disease in relation to anthropometric measures in nonalcoholic fatty liver disease patients following dietary intervention.

Kaczorowska M, Ryterska K, Ossowski P, Maciejewska D, Sabinicz A, Jamioł-Milc D, Raszeja -Wyszomirska J, Stachowska E.

Pomeranian J Life Sci. 2016;62(2):8-14.

PMID:
29537209
32.

Assessment of health related quality of life in polish patients with primary biliary cirrhosis.

Raszeja-Wyszomirska J, Wunsch E, Krawczyk M, Rigopoulou EI, Kostrzewa K, Norman GL, Bogdanos DP, Milkiewicz P.

Clin Res Hepatol Gastroenterol. 2016 Sep;40(4):471-9. doi: 10.1016/j.clinre.2015.10.006. Epub 2015 Nov 24.

PMID:
26621536
33.

Leisure time physical activity and health-related behaviours after liver transplantation: a prospective, single-centre study.

Kotarska K, Wunsch E, Raszeja-Wyszomirska J, Kempińska-Podhorodecka A, Wójcicki M, Milkiewicz P.

Prz Gastroenterol. 2015;10(2):100-4. doi: 10.5114/pg.2015.49002. Epub 2015 Feb 8.

34.

Metabolites of arachidonic acid and linoleic acid in early stages of non-alcoholic fatty liver disease--A pilot study.

Maciejewska D, Ossowski P, Drozd A, Ryterska K, Jamioł-Milc D, Banaszczak M, Kaczorowska M, Sabinicz A, Raszeja-Wyszomirska J, Stachowska E.

Prostaglandins Other Lipid Mediat. 2015 Sep;121(Pt B):184-9. doi: 10.1016/j.prostaglandins.2015.09.003. Epub 2015 Sep 25.

PMID:
26408952
35.

Evolution Of The Results Of 1500 Liver Transplantations Performed In The Department Of General, Transplant And Liver Surgery Medical University Of Warsaw.

Krawczyk M, Grąt M, Grąt K, Wronka K, Krasnodębski M, Stypułkowski J, Masior Ł, Hołówko W, Ligocka J, Nyckowski P, Wróblewski T, Paluszkiewicz R, Patkowski W, Zieniewicz K, Pączek L, Milkiewicz P, Ołdakowska-Jedynak U, Najnigier B, Dudek K, Remiszewski P, Grzelak I, Kornasiewicz O, Kotulski M, Smoter P, Grodzicki M, Korba M, Kalinowski P, Skalski M, Zając K, Stankiewicz R, Przybysz M, Cieślak B, Nazarewski Ł, Nowosad M, Kobryń K, Wasilewicz M, Raszeja-Wyszomirska J, Piwowarska J, Giercuszkiewicz D, Sańko-Resmer J, Rejowski S, Szydłowska-Jakimiuk M, Górnicka B, Wróblewska-Ziarkiewicz B, Mazurkiewicz M, Niewiński G, Pawlak J, Pacho R.

Pol Przegl Chir. 2015 May;87(5):221-30. doi: 10.1515/pjs-2015-0046.

PMID:
26172161
36.

Female Sex But Not Original Indication Affects Physical Activity After Liver Transplant: A Prospective, Single Center Study.

Kotarska K, Wunsch E, Raszeja-Wyszomirska J, Kempińska-Podhorodecka A, Wójcicki M, Milkiewicz P.

Exp Clin Transplant. 2015 Jun;13(3):243-6.

37.

The impact of fragility fractures on health-related quality of life in patients with primary sclerosing cholangitis.

Raszeja-Wyszomirska J, Kucharski R, Zygmunt M, Safranow K, Miazgowski T.

Hepat Mon. 2015 Apr 25;15(4):e25539. doi: 10.5812/hepatmon.25539. eCollection 2015 Apr.

38.

Fatty acid changes help to better understand regression of nonalcoholic fatty liver disease.

Maciejewska D, Drozd A, Ossowski P, Ryterska K, Jamioł-Milc D, Banaszczak M, Raszeja-Wyszomirska J, Kaczorowska M, Sabinicz A, Stachowska E.

World J Gastroenterol. 2015 Jan 7;21(1):301-10. doi: 10.3748/wjg.v21.i1.301.

39.

Ferroportin-related haemochromatosis associated with novel Y64H mutation of the SCL40A1 gene.

Raszeja-Wyszomirska J, Caleffi A, Milkiewicz P, Pietrangelo A.

Prz Gastroenterol. 2014;9(5):307-9. doi: 10.5114/pg.2014.46167. Epub 2014 Oct 19.

40.

Prospective evaluation of PBC-specific health-related quality of life questionnaires in patients with primary sclerosing cholangitis.

Raszeja-Wyszomirska J, Wunsch E, Krawczyk M, Rigopoulou EI, Bogdanos D, Milkiewicz P.

Liver Int. 2015 Jun;35(6):1764-71. doi: 10.1111/liv.12730. Epub 2014 Dec 4.

PMID:
25388280
41.

Osteoporosis in primary biliary cirrhosis of the liver.

Raszeja-Wyszomirska J, Miazgowski T.

Prz Gastroenterol. 2014;9(2):82-7. doi: 10.5114/pg.2014.42502. Epub 2014 May 5. Review.

42.

Synchronous and metachronous neoplasms in gastric cancer patients: a 23-year study.

Ławniczak M, Gawin A, Jaroszewicz-Heigelmann H, Rogoza-Mateja W, Raszeja-Wyszomirska J, Białek A, Karpińska-Kaczmarczyk K, Starzyńska T.

World J Gastroenterol. 2014 Jun 21;20(23):7480-7. doi: 10.3748/wjg.v20.i23.7480.

43.

Factors affecting health-related quality of life and physical activity after liver transplantation for autoimmune and nonautoimmune liver diseases: a prospective, single centre study.

Kotarska K, Wunsch E, Kempińska-Podhorodecka A, Raszeja-Wyszomirska J, Bogdanos DP, Wójcicki M, Milkiewicz P.

J Immunol Res. 2014;2014:738297. doi: 10.1155/2014/738297. Epub 2014 Mar 4.

44.

Prospective evaluation of ursodeoxycholic acid withdrawal in patients with primary sclerosing cholangitis.

Wunsch E, Trottier J, Milkiewicz M, Raszeja-Wyszomirska J, Hirschfield GM, Barbier O, Milkiewicz P.

Hepatology. 2014 Sep;60(3):931-40. doi: 10.1002/hep.27074. Epub 2014 Jul 30.

PMID:
24519384
45.

TRAF1-C5 affects quality of life in patients with primary biliary cirrhosis.

Raszeja-Wyszomirska J, Wunsch E, Kempinska-Podhorodecka A, Smyk DS, Bogdanos DP, Milkiewicz M, Milkiewicz P.

Clin Dev Immunol. 2013;2013:510547. doi: 10.1155/2013/510547. Epub 2013 Apr 28.

46.

Primary Budd-Chiari syndrome - a single center experience.

Raszeja-Wyszomirska J, Mieżyńska-Kurtycz J, Marlicz W, Lawniczak M, Wójcicki M.

Hepatogastroenterology. 2012 Sep;59(118):1879-82. doi: 10.5754/hge11064.

PMID:
22819909
47.

Lipidic last breath of life in patients with alcoholic liver disease.

Raszeja-Wyszomirska J, Safranow K, Milkiewicz M, Milkiewicz P, Szynkowska A, Stachowska E.

Prostaglandins Other Lipid Mediat. 2012 Oct;99(1-2):51-6. doi: 10.1016/j.prostaglandins.2012.06.001. Epub 2012 Jun 15.

PMID:
22706383
48.

Vitamin d receptor polymorphisms predispose to primary biliary cirrhosis and severity of the disease in polish population.

Kempińska-Podhorecka A, Wunsch E, Jarowicz T, Raszeja-Wyszomirska J, Loniewska B, Kaczmarczyk M, Milkiewicz M, Milkiewicz P.

Gastroenterol Res Pract. 2012;2012:408723. doi: 10.1155/2012/408723. Epub 2012 May 29.

49.

[Wilson's disease].

Ławniczak M, Raszeja-Wyszomirska J, Starzyńska T.

Pol Merkur Lekarski. 2010 Aug;29(170):125-7. Review. Polish.

PMID:
20842827
50.

Validation of the BARD scoring system in Polish patients with nonalcoholic fatty liver disease (NAFLD).

Raszeja-Wyszomirska J, Szymanik B, Ławniczak M, Kajor M, Chwist A, Milkiewicz P, Hartleb M.

BMC Gastroenterol. 2010 Jun 28;10:67. doi: 10.1186/1471-230X-10-67.

Supplemental Content

Loading ...
Support Center